July 2019 - Volume 31 - Issue 7 - Contributor Index

Alphabetical Search
U
Author:
Abe, Masanori

Can L-carnitine supplementation and exercise improve muscle complications in patients with liver cirrhosis who receive branched-chain amino acid supplementation?

Hiraoka, Atsushi; Kiguchi, Daisuke; Ninomiya, Tomoyuki; More

European Journal of Gastroenterology & Hepatology. 31(7):878-884, July 2019.

Author:
Ahmed, Azza M.
Author:
Akinci, Hakan
Author:
Akyuz, Filiz

Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?

Akyuz, Filiz; Cavus, Bilger; Iliaz, Raim; More

European Journal of Gastroenterology & Hepatology. 31(7):777-780, July 2019.

Author:
Alkan, Afra
Author:
An, Hyun Young

Prevalence of Clostridium difficile infection among hospitalized inflammatory bowel disease patients in Greece

Viazis, Nikos; Pontas, Christos; Karmiris, Konstantinos; More

European Journal of Gastroenterology & Hepatology. 31(7):773-776, July 2019.

Prevalence of Clostridium difficile infection among hospitalized inflammatory bowel disease patients in Greece

Viazis, Nikos; Pontas, Christos; Karmiris, Konstantinos; More

European Journal of Gastroenterology & Hepatology. 31(7):773-776, July 2019.

Author:
Banasa, Maria

Prevalence of Clostridium difficile infection among hospitalized inflammatory bowel disease patients in Greece

Viazis, Nikos; Pontas, Christos; Karmiris, Konstantinos; More

European Journal of Gastroenterology & Hepatology. 31(7):773-776, July 2019.

Prevalence of Clostridium difficile infection among hospitalized inflammatory bowel disease patients in Greece

Viazis, Nikos; Pontas, Christos; Karmiris, Konstantinos; More

European Journal of Gastroenterology & Hepatology. 31(7):773-776, July 2019.

Author:
Berg, Thomas

Risk factors for resistance development against lamivudine during long-term treatment of chronic hepatitis B virus infections

Koukoulioti, Eleni; Brodzinski, Annika; Mihm, Ulrike; More

European Journal of Gastroenterology & Hepatology. 31(7):845-852, July 2019.

Author:
Besisik, Fatih

Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?

Akyuz, Filiz; Cavus, Bilger; Iliaz, Raim; More

European Journal of Gastroenterology & Hepatology. 31(7):777-780, July 2019.

Risk factors for resistance development against lamivudine during long-term treatment of chronic hepatitis B virus infections

Koukoulioti, Eleni; Brodzinski, Annika; Mihm, Ulrike; More

European Journal of Gastroenterology & Hepatology. 31(7):845-852, July 2019.

Author:
Cagatay, Tulin

Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?

Akyuz, Filiz; Cavus, Bilger; Iliaz, Raim; More

European Journal of Gastroenterology & Hepatology. 31(7):777-780, July 2019.

Author:
Cai, Hui-Yang
Author:
Cai, Li-rong

Tenofovir and telbivudine combination therapy rapidly decreases viral loads in immune-tolerant chronic hepatitis B patients awaiting assisted reproduction: an open-label, randomized, controlled study

Wu, Zhi-xian; Chen, Feng-sui; Zhou, Xiao-ling; More

European Journal of Gastroenterology & Hepatology. 31(7):832-835, July 2019.

Author:
Cai, Meng-Xing
Author:
Cavus, Bilger

Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?

Akyuz, Filiz; Cavus, Bilger; Iliaz, Raim; More

European Journal of Gastroenterology & Hepatology. 31(7):777-780, July 2019.

Author:
Chen, Feng-sui

Tenofovir and telbivudine combination therapy rapidly decreases viral loads in immune-tolerant chronic hepatitis B patients awaiting assisted reproduction: an open-label, randomized, controlled study

Wu, Zhi-xian; Chen, Feng-sui; Zhou, Xiao-ling; More

European Journal of Gastroenterology & Hepatology. 31(7):832-835, July 2019.

Author:
Chen, Wei-Zhe
Author:
Chen, Wenguo
Author:
Chen, Xi-Yi
Author:
Chen, Xiao-Lie
Author:
Chen, Xueyang
Author:
Coskun, Yusuf
Author:
Cui, Ruixia

Prognostic predictors for patients with hepatocellular carcinoma receiving adjuvant transcatheter arterial chemoembolization

Gu, Jingxian; Zhang, Xing; Cui, Ruixia; More

European Journal of Gastroenterology & Hepatology. 31(7):836-844, July 2019.

Author:
Demir, Kadir

Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?

Akyuz, Filiz; Cavus, Bilger; Iliaz, Raim; More

European Journal of Gastroenterology & Hepatology. 31(7):777-780, July 2019.

Author:
Dhir, Vinita
Author:
Dimas, Ioannis

Prevalence of Clostridium difficile infection among hospitalized inflammatory bowel disease patients in Greece

Viazis, Nikos; Pontas, Christos; Karmiris, Konstantinos; More

European Journal of Gastroenterology & Hepatology. 31(7):773-776, July 2019.

Author:
Dong, Qian-Tong
Author:
Dong, Yanyan

Prognostic predictors for patients with hepatocellular carcinoma receiving adjuvant transcatheter arterial chemoembolization

Gu, Jingxian; Zhang, Xing; Cui, Ruixia; More

European Journal of Gastroenterology & Hepatology. 31(7):836-844, July 2019.

Prevalence of Clostridium difficile infection among hospitalized inflammatory bowel disease patients in Greece

Viazis, Nikos; Pontas, Christos; Karmiris, Konstantinos; More

European Journal of Gastroenterology & Hepatology. 31(7):773-776, July 2019.

Author:
Du, Haojie
Author:
Du, Shuai
Author:
Evirgen, Sami

Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?

Akyuz, Filiz; Cavus, Bilger; Iliaz, Raim; More

European Journal of Gastroenterology & Hepatology. 31(7):777-780, July 2019.

Author:
Fan, Haining

Prognostic predictors for patients with hepatocellular carcinoma receiving adjuvant transcatheter arterial chemoembolization

Gu, Jingxian; Zhang, Xing; Cui, Ruixia; More

European Journal of Gastroenterology & Hepatology. 31(7):836-844, July 2019.

Author:
Feng, Wei
Author:
Fragaki, Maria

Prevalence of Clostridium difficile infection among hospitalized inflammatory bowel disease patients in Greece

Viazis, Nikos; Pontas, Christos; Karmiris, Konstantinos; More

European Journal of Gastroenterology & Hepatology. 31(7):773-776, July 2019.

Author:
Friedland, Shai
Author:
Fülöp, Balazs

Risk factors for resistance development against lamivudine during long-term treatment of chronic hepatitis B virus infections

Koukoulioti, Eleni; Brodzinski, Annika; Mihm, Ulrike; More

European Journal of Gastroenterology & Hepatology. 31(7):845-852, July 2019.

Author:
Gao, Feng
Author:
Gao, Yanhang
Author:
Gu, Jingxian

Prognostic predictors for patients with hepatocellular carcinoma receiving adjuvant transcatheter arterial chemoembolization

Gu, Jingxian; Zhang, Xing; Cui, Ruixia; More

European Journal of Gastroenterology & Hepatology. 31(7):836-844, July 2019.

Author:
Gu, Jueqing

Serum alkaline phosphatase levels as a simple and useful test in screening for significant fibrosis in treatment-naive patients with hepatitis B e-antigen negative chronic hepatitis B

Hu, Jianhua; Zhang, Xiaoli; Gu, Jueqing; More

European Journal of Gastroenterology & Hepatology. 31(7):817-823, July 2019.

Author:
Gulluoglu, Mine

Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?

Akyuz, Filiz; Cavus, Bilger; Iliaz, Raim; More

European Journal of Gastroenterology & Hepatology. 31(7):777-780, July 2019.

Author:
Guo, Huiwen
Author:
Hamamci, Mevlut
Author:
He, Ze-Bao
Author:
Helwig, Ulf
Author:
Heo, Nae-Yun
Author:
Hiasa, Yoichi

Can L-carnitine supplementation and exercise improve muscle complications in patients with liver cirrhosis who receive branched-chain amino acid supplementation?

Hiraoka, Atsushi; Kiguchi, Daisuke; Ninomiya, Tomoyuki; More

European Journal of Gastroenterology & Hepatology. 31(7):878-884, July 2019.

Can L-carnitine supplementation and exercise improve muscle complications in patients with liver cirrhosis who receive branched-chain amino acid supplementation?

Hiraoka, Atsushi; Kiguchi, Daisuke; Ninomiya, Tomoyuki; More

European Journal of Gastroenterology & Hepatology. 31(7):878-884, July 2019.

Can L-carnitine supplementation and exercise improve muscle complications in patients with liver cirrhosis who receive branched-chain amino acid supplementation?

Hiraoka, Atsushi; Kiguchi, Daisuke; Ninomiya, Tomoyuki; More

European Journal of Gastroenterology & Hepatology. 31(7):878-884, July 2019.

Author:
Hu, Jianhua

Serum alkaline phosphatase levels as a simple and useful test in screening for significant fibrosis in treatment-naive patients with hepatitis B e-antigen negative chronic hepatitis B

Hu, Jianhua; Zhang, Xiaoli; Gu, Jueqing; More

European Journal of Gastroenterology & Hepatology. 31(7):817-823, July 2019.

Author:
Huang, Qian

Tenofovir and telbivudine combination therapy rapidly decreases viral loads in immune-tolerant chronic hepatitis B patients awaiting assisted reproduction: an open-label, randomized, controlled study

Wu, Zhi-xian; Chen, Feng-sui; Zhou, Xiao-ling; More

European Journal of Gastroenterology & Hepatology. 31(7):832-835, July 2019.

Author:
Huang, Zhi-Ming
Author:
Iliaz, Raim

Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?

Akyuz, Filiz; Cavus, Bilger; Iliaz, Raim; More

European Journal of Gastroenterology & Hepatology. 31(7):777-780, July 2019.

Author:
Jang, Ji Woong
Author:
Jessen, Petra
Author:
Jia, Yifan

Prognostic predictors for patients with hepatocellular carcinoma receiving adjuvant transcatheter arterial chemoembolization

Gu, Jingxian; Zhang, Xing; Cui, Ruixia; More

European Journal of Gastroenterology & Hepatology. 31(7):836-844, July 2019.

Author:
Jin, Young-Joo
Author:
Jung, Dae Ho

Risk factors for resistance development against lamivudine during long-term treatment of chronic hepatitis B virus infections

Koukoulioti, Eleni; Brodzinski, Annika; Mihm, Ulrike; More

European Journal of Gastroenterology & Hepatology. 31(7):845-852, July 2019.

Author:
Karaca, Cetin

Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?

Akyuz, Filiz; Cavus, Bilger; Iliaz, Raim; More

European Journal of Gastroenterology & Hepatology. 31(7):777-780, July 2019.

Prevalence of Clostridium difficile infection among hospitalized inflammatory bowel disease patients in Greece

Viazis, Nikos; Pontas, Christos; Karmiris, Konstantinos; More

European Journal of Gastroenterology & Hepatology. 31(7):773-776, July 2019.

Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?

Akyuz, Filiz; Cavus, Bilger; Iliaz, Raim; More

European Journal of Gastroenterology & Hepatology. 31(7):777-780, July 2019.

Author:
Keskin, Metin

Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?

Akyuz, Filiz; Cavus, Bilger; Iliaz, Raim; More

European Journal of Gastroenterology & Hepatology. 31(7):777-780, July 2019.

Can L-carnitine supplementation and exercise improve muscle complications in patients with liver cirrhosis who receive branched-chain amino acid supplementation?

Hiraoka, Atsushi; Kiguchi, Daisuke; Ninomiya, Tomoyuki; More

European Journal of Gastroenterology & Hepatology. 31(7):878-884, July 2019.

Author:
Kim, Won Young
Author:
Kim, Youn-Jung
Author:
Ko, Byuk Sung
Author:
Koksalan, Kaya

Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?

Akyuz, Filiz; Cavus, Bilger; Iliaz, Raim; More

European Journal of Gastroenterology & Hepatology. 31(7):777-780, July 2019.

Risk factors for resistance development against lamivudine during long-term treatment of chronic hepatitis B virus infections

Koukoulioti, Eleni; Brodzinski, Annika; Mihm, Ulrike; More

European Journal of Gastroenterology & Hepatology. 31(7):845-852, July 2019.

Prevalence of Clostridium difficile infection among hospitalized inflammatory bowel disease patients in Greece

Viazis, Nikos; Pontas, Christos; Karmiris, Konstantinos; More

European Journal of Gastroenterology & Hepatology. 31(7):773-776, July 2019.

Prevalence of Clostridium difficile infection among hospitalized inflammatory bowel disease patients in Greece

Viazis, Nikos; Pontas, Christos; Karmiris, Konstantinos; More

European Journal of Gastroenterology & Hepatology. 31(7):773-776, July 2019.

Author:
Lai, Shih-Wei
Author:
Lee, Jin-Woo
Author:
Leng, Xiafei
Author:
Li, Dong-liang

Tenofovir and telbivudine combination therapy rapidly decreases viral loads in immune-tolerant chronic hepatitis B patients awaiting assisted reproduction: an open-label, randomized, controlled study

Wu, Zhi-xian; Chen, Feng-sui; Zhou, Xiao-ling; More

European Journal of Gastroenterology & Hepatology. 31(7):832-835, July 2019.

Author:
Li, Guochuang
Author:
Li, Lanjuan

Serum alkaline phosphatase levels as a simple and useful test in screening for significant fibrosis in treatment-naive patients with hepatitis B e-antigen negative chronic hepatitis B

Hu, Jianhua; Zhang, Xiaoli; Gu, Jueqing; More

European Journal of Gastroenterology & Hepatology. 31(7):817-823, July 2019.

Author:
Li, Sha